Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.84 is 26% below its 5-year average of 3.87, near the low end of its 5-year range (1.53–28.92).
As of the fiscal period ended Tuesday, June 30, 2026. 24.26% below its 12-month average of 3.75.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.84.
CURRENT RATIO
2.84
CURRENT RATIO AVG TTM
3.75
CURRENT RATIO AVG 3Y
4.55
CURRENT RATIO AVG 5Y
3.87
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.26%
CURRENT VS 3Y AVG
-37.56%
CURRENT VS 5Y AVG
-26.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-24.39%
vs the sector median at left
Market Cap
$42.72M
Current Ratio
2.55
TTM Avg
3.96
3Y Avg
5.38
5Y Avg
6.26
Market Cap
$42.26M
Current Ratio
2.08
TTM Avg
2.23
3Y Avg
2.23
5Y Avg
2.23
Market Cap
$41.95M
Current Ratio
0.98
TTM Avg
2.74
3Y Avg
1.63
5Y Avg
1.13
Market Cap
$44.72M
Current Ratio
2.91
TTM Avg
4.54
3Y Avg
5.51
5Y Avg
8.87
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $42.83M | 2.84 | 3.75 | 4.55 | 3.87 |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | 2.55 | 3.96 | 5.38 | 6.26 |
| CVRx, Inc. (CVRX)vs › | $42.99M | 8.04 | 9.85 | 12.28 | 13.79 |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | 2.08 | 2.23 | 2.23 | 2.23 |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | 0.98 | 2.74 | 1.63 | 1.13 |
| Precipio, Inc. (PRPO)vs › | $41.83M | 1.77 | 1.21 | 1.23 | 1.50 |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 2.31 | 3.08 | 3.34 | 3.56 |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 1.28 | 0.90 | 0.52 | 0.40 |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | 2.91 | 4.54 | 5.51 | 8.87 |
| Celularity Inc. (CELU)vs › | $45.73M | 0.09 | 0.27 | 0.34 | 1.05 |
Current Ratio
2.84
Quick Ratio
2.59
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.84 |
| 2026-03-31 | 3.64 |
| 2025-12-31 | 3.96 |
| 2025-09-30 | 4.14 |
| 2025-06-30 | 4.19 |
| 2025-03-31 | 5.30 |
| 2024-12-31 | 5.63 |
| 2024-09-30 | 4.64 |
| 2024-06-30 | 5.16 |
| 2024-03-31 | 5.81 |
| 2023-12-31 | 5.71 |
| 2023-09-30 | 4.87 |
| 2023-06-30 | 3.31 |
| 2023-03-31 | 3.39 |
| 2022-12-31 | 3.29 |
| 2022-09-30 | 2.08 |
| 2022-06-30 | 2.21 |
| 2022-03-31 | 1.53 |
| 2021-12-31 | 1.80 |
| 2021-09-30 | 17.96 |
| 2021-06-30 | 28.92 |
| 2021-03-31 | 12.15 |
| 2020-12-31 | 49.06 |
| 2020-09-30 | 40.13 |
| 2020-06-30 | 15.54 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.48 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
